-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-27 Immune Tolerance by Red Cells

Program: Scientific Program
Session: Novel Blood Therapeutics
Saturday, December 5, 2020, 9:25 AM-9:30 AM

Hidde L. Ploegh, PhD

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA

Disclosures: No relevant conflicts of interest to declare.

See more of: Novel Blood Therapeutics
See more of: Scientific Program
<< Previous Presentation | Next Presentation >>